ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Breathing Regulation Training for Individuals With Panic Disorder

This study is currently recruiting participants.
Study NCT00183521.   Last updated on September 19, 2008.   Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Breathing Regulation Training for Individuals With Panic Disorder
Official Title  Respiratory Therapeutic Procedures in Panic Disorder
Brief Summary

This study will compare two different breathing regulation techniques to determine which is more effective in reducing the rate of panic attacks in people with panic disorder.

Detailed Description

PD is a serious condition characterized by episodes of rapid heart rate, difficulty breathing, and other symptoms of fear. Explanations for panic attacks have been proposed in two theories: suffocation alarm theory and hyperventilation theory. The suffocation alarm theory claims that panic attacks are due to a "suffocation monitor" in the brain, erroneously signaling a lack of useful air. The hyperventilation theory suggests that stressful events cause people to slightly hyperventilate; some people have panic attacks as a result of their overreaction to the dizziness and lightheadedness they feel from hyperventilation. Both theories note the role of carbon dioxide (CO2) in panic attacks; they suggest that rising CO2 levels in arterial blood act as a panic stimulus. This study will compare two types of breathing regulation techniques based on the panic attack theories to determine which is more effective in reducing panic symptoms in people with PD.

This study will last 4 weeks and will include both people with PD and those without the condition. Participants will be randomly assigned to one of three groups: raise-CO2 breathing, lower-CO2 breathing, or a control group. Participants in both the raise-CO2 and lower-CO2 breathing groups will have five sessions of training in which they will learn specific breathing techniques. Participants in the raise-CO2 group will be taught techniques to recover from hyperventilation faster; participants in the lower-CO2 group will be taught techniques to reach hyperventilation levels, then switch to breathing techniques that reduce hyperventilation symptoms. Participants in the control group will not be taught any breathing techniques but will be included in all assessments.

Participants will be assessed at study entry, during each breathing training session, and at Months 1 and 6 after the study. During each assessment, questionnaires and self-report scales will be used to measure cognitive, psychological, and physiological changes related to participants' breathing.

Study Phase
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Parallel Assignment, Efficacy Study
Primary Outcome Measure  Breathing regulation [ Time Frame: Measured at Month 6 after completion of therapy ] [ Designated as safety issue: No ]
Secondary Outcome Measure 
Condition  Panic Disorder
Intervention  Behavioral: Raise-CO2 breathing regulation training
Behavioral: Lower-CO2 breathing regulation training
Behavioral: Control
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  100
Start Date  March 2005
Completion Date June 2008
Eligibility Criteria 

Inclusion Criteria for Participants With PD:

  • Diagnosis of PD
  • History of panic attacks that are at least moderately severe in frequency and severity
  • Able and willing to comply with all study requirements

Exclusion Criteria for All Participants:

  • History of chest pain, heart attack, congestive heart failure, or clinically significant irregular heartbeat
  • History of blood circulation problems or cerebrovascular accidents
  • Diabetes mellitus
  • Asthma or chronic obstructive pulmonary disease (COPD)
  • History of schizophrenia, bipolar disorder, or dementia
  • Drugs which would affect breathing
  • Alcohol or other substance abuse within 1 year prior to study entry
  • Current use of any recreational drugs or consumption of more than 15 alcoholic drinks per week

Exclusion Criteria for Participants Without PD:

  • History of anxiety disorders
Gender Both
Ages 18 Years to 60 Years
Accepts Healthy Volunteers Yes
Contacts ††
Contact: Walton T. Roth, MD     650-493-5000 ext 65243     wtroth@stanford.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00183521
Organization ID R01 MH66953
Secondary IDs †† DATR A2-AIR
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Walton T. Roth, MD     Stanford University and VA Health Care System    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date September 2008
First Received Date  September 13, 2005
Last Updated Date September 19, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers